Australian drug developer Biotron may have found a potential cure for Hepatitis C, after all patients who completed a trial of its lead antiviral drug emerged with undetectable levels of the virus.

When the IBM PC was new, I served as the president of the San Francisco PC User Group for three years. That’s how I met PCMag’s editorial team, who brought me on board in 1986. In the years since that ...

This scheme has consistently delivered the best returns in its Medium Duration category across . This scheme has maintained a relatively low level of volatility within its Medium Duration category ...

This scheme has consistently delivered the best returns in its Multi Asset Allocation category across . This scheme's Assets Under Management (₹52.84 Crores) are amongst the lowest in its Multi Asset ...